Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus (Q90854036)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

title

Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

author name string

Donghui Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Liang Ji

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Mingming Zhao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Yang Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Yansong Guo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Ling Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Dongmei Zhang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Liang Xu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Bing Pan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Jinzi Su

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Subramaniam Pennathur

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Jingxuan Li

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Jianing Gao

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Pingsheng Liu

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Belinda Willard

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

Lemin Zheng

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

publication date

7 August 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

16 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

volume

122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

page(s)

47-57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

Atherosclerosis: current pathogenesis and therapeutic options

16 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Dysfunctional HDL and atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Advances in high-density lipoprotein physiology: surprises, overturns, and promises

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Why is HDL functionally deficient in type 2 diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Diabetic HDL is dysfunctional in stimulating endothelial cell migration and proliferation due to down regulation of SR-BI expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

HDL of patients with type 2 diabetes mellitus elevates the capability of promoting breast cancer metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Nonenzymatic glycation of high‐density lipoprotein impairs its anti‐inflammatory effects in innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Human apolipoprotein A-I induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through ATP-binding cassette transporter A1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Quantitative dynamics of site-specific protein phosphorylation determined using liquid chromatography electrospray ionization mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Site-specific quantitation of protein nitration using liquid chromatography/tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

19 Receptor-mediated endocytosis of low-density lipoprotein in cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

ABCA1-induced cell surface binding sites for ApoA-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Hidden Complexities in the Measurement of Fructosyl-Lysine and Advanced Glycation End Products for Risk Prediction of Vascular Complications of Diabetes: Figure 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

High-density lipoprotein nitration and chlorination catalyzed by myeloperoxidase impair its effect of promoting endothelial repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Nonenzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Role of apolipoprotein A-I in protecting against endotoxin toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Structural models of human apolipoprotein A-I: a critical analysis and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Truncation of the amino terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Deletion of the C-terminal domain of apolipoprotein A-I impairs cell surface binding and lipid efflux in macrophage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Deletion of central alpha-helices in human apolipoprotein A-I: effect on phospholipid association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Distinct central amphipathic alpha-helices in apolipoprotein A-I contribute to the in vivo maturation of high density lipoprotein by either activating lecithin-cholesterol acyltransferase or binding lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Identification of Two Apolipoprotein Variants, A-I Kaho (Asp 51^|^rarr;Val) and A-I Lys 107 Deletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

Glycation of apoprotein A-I is associated with coronary artery plaque progression in type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2018.08.001

10.1016/J.YJMCC.2018.08.001

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092227 AND SRC:MED&resulttype=core&format=json

16 April 2020

1 reference